Protocol B1971011: A Phase 2, Randomized, Single-Blind Trial, To Asess the Safety, Tolerability and Immunogenicity of Gardasil Vaccine and rLP2086 Vaccine When Administered Concomitantly in Healthy Subjects Aged >/= 11 to </=17 Years

Project: Other project

StatusFinished
Effective start/end date8/1/111/1/15

Funding

  • Pfizer, Inc.: $105,240.18